Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile Infection

Clinical trial NCT00772343 · COMPLETED

Trial details

NCT number: NCT00772343
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diarrhea Clostridium Difficile Infection

Start date: 2009-02-01
Primary completion: 2011-07-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.